{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:57:21Z","timestamp":1781308641905,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X020258\/1"],"award-info":[{"award-number":["MR\/X020258\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001125","name":"GAVI the Vaccine Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["INV-034281"],"award-info":[{"award-number":["INV-034281"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128477","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:59:11Z","timestamp":1773309551000},"page":"128477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sociodemographic factors influencing COVID-19 vaccine uptake and dropout rates in England"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1724-7817","authenticated-orcid":false,"given":"Camila","family":"Llanes-Kidder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Gaythorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2026.128477_b1","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of patients with 2019 novel coronavirus (2019-nCoV)\u2013Infected pneumonia in wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128477_b2","series-title":"Coronavirus disease (COVID-19) pandemic","author":"World Health Organisation","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128477_b3","series-title":"Coronavirus: A history of English lockdown laws.","author":"Brown","year":"2021"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128477_b4","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(22)00337-1","article-title":"Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study","volume":"8","author":"Imai","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.vaccine.2026.128477_b5","series-title":"Regulatory approval of spikevax (formerly COVID-19 vaccine moderna)","author":"Medicines & Healthcare products Regulatory Agency","year":"2021"},{"key":"10.1016\/j.vaccine.2026.128477_b6","series-title":"Coronavirus vaccine - summary of yellow card reporting","author":"Medicines & Healthcare products Regulatory Agency","year":"2023"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128477_b7","article-title":"The rapid progress in COVID vaccine development and implementation","volume":"7","author":"Barrett","year":"2022","journal-title":"Npj Vaccines 2022 7:1"},{"key":"10.1016\/j.vaccine.2026.128477_b8","series-title":"Optimising the COVID-19 vaccination programme for maximum short-term impact","author":"Department of Health & Social Care","year":"2021"},{"key":"10.1016\/j.vaccine.2026.128477_b9","article-title":"Coronavirus pandemic (COVID-19)","author":"Mathieu","year":"2020","journal-title":"Our World Data"},{"key":"10.1016\/j.vaccine.2026.128477_b10","series-title":"Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients\u2019 primary care records in situ using opensafely","author":"Curtis","year":"2021"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128477_b11","doi-asserted-by":"crossref","DOI":"10.1093\/pubmed\/fdab400","article-title":"COVID-19 vaccination uptake amongst ethnic minority communities in England: a linked study exploring the drivers of differential vaccination rates","volume":"45","author":"Gaughan","year":"2023","journal-title":"J Public Health (Oxford, England)"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128477_b12","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2017.1417632","article-title":"Challenges in adult vaccination","volume":"50","author":"Gomensoro","year":"2018","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128477_b13","article-title":"Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review","volume":"16","author":"Gallagher","year":"2016","journal-title":"BMC Public Health 2016 16:1"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128477_b14","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2018.1467200","article-title":"The impact of dosing schedules on the success of vaccination programmes in elderly populations: A summary of current evidence","volume":"14","author":"Matthews","year":"2018","journal-title":"Hum Vaccines & Immunother"},{"key":"10.1016\/j.vaccine.2026.128477_b15","unstructured":"European Commission. Vaccination programmes and health systems in the European Union. Report, 2018, http:\/\/dx.doi.org\/10.2875\/18503, URL https:\/\/health.ec.europa.eu\/document\/download\/3d13f27c-3567-427c-821f-a828c45a481b_en."},{"key":"10.1016\/j.vaccine.2026.128477_b16","series-title":"The impact of health inequity on regional variation of COVID-19 transmission in England","author":"Rawson","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128477_b17","series-title":"Population estimates for the UK, England and Wales, Scotland and Northern Ireland: mid-2020","author":"Office for National Statistics","year":"2021"},{"key":"10.1016\/j.vaccine.2026.128477_b18","series-title":"Population of the UK by country of birth and nationality: 2016","author":"Office for National Statistics","year":"2017"},{"key":"10.1016\/j.vaccine.2026.128477_b19","series-title":"Annual survey of hours and earnings (ASHE)","author":"Office for National Statistics","year":"2021"},{"key":"10.1016\/j.vaccine.2026.128477_b20","series-title":"2011 Census","author":"Nomis","year":"2011"},{"key":"10.1016\/j.vaccine.2026.128477_b21","series-title":"English indices of deprivation 2019","author":"Ministry of Housing Communities & Local Government, GOV.UK","year":"2019"},{"key":"10.1016\/j.vaccine.2026.128477_b22","series-title":"Allocations for 2019\/20 to 2023\/24","author":"NHS England","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128477_b23","series-title":"Coronavirus (COVID-19): emergency funding for local government in 2020 to 2021 and additional support in 2021 to 2022","author":"Ministry of Housing Communities & Local Government, Department for Levelling Up Housing and Communities","year":"2022"},{"key":"10.1016\/j.vaccine.2026.128477_b24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2021.03.008","article-title":"Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study","volume":"94","author":"Robertson","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128477_b25","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bjhp.12606","article-title":"Perceived threat of COVID-19, attitudes towards vaccination, and vaccine hesitancy: A prospective longitudinal study in the UK","volume":"27","author":"Phillips","year":"2022","journal-title":"Br J Health Psychol"},{"key":"10.1016\/j.vaccine.2026.128477_b26","series-title":"lme4: Linear mixed-effects models using \u2019eigen\u2019 and S4","author":"Bates","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128477_b27","doi-asserted-by":"crossref","first-page":"A132","DOI":"10.1016\/j.vaccine.2019.08.086","article-title":"Global oral cholera vaccine use, 2013\u20132018","volume":"38","author":"Pezzoli","year":"2020","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128477_b28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-089764","article-title":"Machine learning algorithms for prediction of measles one vaccination dropout among 12\u201323 months children in ethiopia","volume":"14","author":"Alemayehu","year":"2024","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128477_b29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003932","article-title":"Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in greater manchester, UK: A cohort study","volume":"19","author":"Watkinson","year":"2022","journal-title":"PLOS Med"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128477_b30","doi-asserted-by":"crossref","DOI":"10.1007\/s40124-022-00278-9","article-title":"Vaccine hesitancy: Obstacles and challenges","volume":"10","author":"Galagali","year":"2022","journal-title":"Curr Pediatr Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128477_b31","article-title":"COVID-19 vaccine hesitancy and short-term and long-term intentions among unvaccinated young adults: a mixed-method approach","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Public Health 2022 22:1"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128477_b32","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11040870","article-title":"Views and perceptions of people aged 55+ on the vaccination programme for older adults in the UK: A qualitative study","volume":"11","author":"Silvonen","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128477_b33","series-title":"WHO\/UNICEF Estimates of National Immunization Coverage, 2024 Revision","author":"World Health Organization","year":"2025"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128477_b34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12939-022-01678-5","article-title":"Vaccine equity in low and middle income countries: a systematic review and meta-analysis","volume":"21","author":"Ali","year":"2022","journal-title":"Int J Equity Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128477_b35","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-019-6597-4","article-title":"Social inequities in vaccination coverage among infants and pre-school children in Europe and Australia\u2013a systematic review.","volume":"19","author":"Arat","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2026.128477_b36","article-title":"Covid-19 vaccine hesitancy among ethnic minority groups - PubMed","volume":"372","author":"Razai","year":"2021","journal-title":"BMJ (Clinical Res Ed)"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128477_b37","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00404-7","article-title":"Lessons about COVID-19 vaccine hesitancy among minority ethnic people in the UK - PubMed","volume":"21","author":"Kadambari","year":"2021","journal-title":"Lancet. Infect Dis"},{"issue":"25","key":"10.1016\/j.vaccine.2026.128477_b38","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2022.04.030","article-title":"Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies","volume":"40","author":"Hussain","year":"2022","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128477_b39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/01410768221095241","article-title":"Racial discrimination, low trust in the health system and COVID-19 vaccine uptake: a longitudinal observational study of 633 UK adults from ethnic minority groups","volume":"115","author":"Paul","year":"2022","journal-title":"J R Soc Med"},{"key":"10.1016\/j.vaccine.2026.128477_b40","series-title":"COVID-19: understanding the impact on BAME communities","author":"Public Health England","year":"2020"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128477_b41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004289","article-title":"Evaluating socioeconomic inequalities in influenza vaccine uptake during the COVID-19 pandemic: A cohort study in greater manchester, England","volume":"20","author":"Watkinson","year":"2023","journal-title":"PLOS Med"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128477_b42","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2022.2052048","article-title":"Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease","volume":"21","author":"Taha","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128477_b43","series-title":"Public health England. National immunisation programme: health equity audit","author":"Public Health England","year":"2021"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128477_b44","article-title":"Identifying people at risk for influenza with low vaccine uptake based on deprivation status: a systematic review","volume":"30","author":"Vukovic","year":"2020","journal-title":"Eur J Pub Health"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128477_b45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ije\/dyg084","article-title":"Neighbourhood deprivation and health: does it affect us all equally?","volume":"32","author":"Stafford","year":"2003","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128477_b46","article-title":"Fear of crime and the environment: systematic review of UK qualitative evidence","volume":"13","author":"Lorenc","year":"2013","journal-title":"BMC Public Health 2013 13:1"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128477_b47","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41467-021-21237-w","article-title":"SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic","volume":"12","author":"Ward","year":"2021","journal-title":"Nat Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:50:17Z","timestamp":1781308217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":47,"alternative-id":["S0264410X26002859"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128477","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sociodemographic factors influencing COVID-19 vaccine uptake and dropout rates in England","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128477"}}